What it sells
Software to launch and integrate genetics into clinical care
Business model breakdown
Buyer: who owns the budget?
UnverifiedHealth systems and clinics running genetic services or precision medicine programs (clinical leaders and genetic services directors).
Trigger: what makes them buy now?
Too few eligible patients get genetic testing and manual referral, consent and ordering workflows are slow; the site claims 40 days saved from referral to results.
Workflow: what inputs become what output?
Identify eligible patients from EMR or patient-reported data, send education and consent, order from the lab of choice, return results and decision support into the EHR, then track program outcomes.
Economics: what it saves and how it charges
Software sold to healthcare organizations; the ROI calculator projects revenue opportunity from recommended medical management changes (e.g. $1,392,000 for an example patient volume).
Distribution: how it reaches customers
Demo-led enterprise sales (Request a Demo), integrates with major EHRs via SMART on FHIR and with multiple labs.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2022 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.